TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 1314965

Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin (1500 a PPT-Units/d Mono-Embolex NM)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Unfractionated heparin (5000 IU t.i.d.)
Number of subjects: 200
Study: 6546602

Group type: EXPERIMENTAL
Intervention: MOPP
Number of subjects: 73

Group type: COMPARATOR
Intervention: OPP
Number of subjects: 73
Study: 29534940

Group type: EXPERIMENTAL
Intervention: Nivolumab
Number of subjects: 2454

Group type: COMPARATOR
Intervention: RECORD-1 and AXIS trials
Number of subjects: 2454

Group type: COMPARATOR
Intervention: INTORSECT trial
Number of subjects: 2454
Study: 27129362

Group type: EXPERIMENTAL
Intervention: DR-HC 5mg
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: DR-HC 20mg
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: DR-HC 15mg (3×5)
Number of subjects: 31
Study: 25604767

Group type: EXPERIMENTAL
Intervention: Community-based intervention including modified insecticide application, education regarding Chagas disease and risk factors, and participatory rodent control.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided).
Number of subjects: 0
Study: 23913972

Group type: EXPERIMENTAL
Intervention: Asoprisnil (a progesterone receptor modulator)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 20367810

Group type: EXPERIMENTAL
Intervention: Education session on SMART Goal Evaluation Method and 3 months of follow-up support (n = 60)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group attended a workshop on evidence-based practice (n = 60)
Number of subjects: 120
Study: 18926878

Group type: EXPERIMENTAL
Intervention: Anodal tDCS of the left temporal cortex (with cathodal stimulation of the right temporal cortex)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 14
Study: 17035531

Group type: EXPERIMENTAL
Intervention: Caffeine (200 mg)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 12412691

Group type: EXPERIMENTAL
Intervention: Endobronchial ultrasound (EBUS) guided TBBX
Number of subjects: 50

Group type: COMPARATOR
Intervention: Fluoroscopy-guided TBBX
Number of subjects: 50
Study: 10101617

Group type: EXPERIMENTAL
Intervention: HIV intervention
Number of subjects: 3357

Group type: EXPERIMENTAL
Intervention: HIV seropositive status
Number of subjects: 3357

Group type: EXPERIMENTAL
Intervention: AIDS information received prior to intervention
Number of subjects: 3357

Group type: EXPERIMENTAL
Intervention: Having multiple sex partners
Number of subjects: 3357

Group type: EXPERIMENTAL
Intervention: Being single with multiple sex partners
Number of subjects: 3357

Group type: EXPERIMENTAL
Intervention: Exchanging drugs or money for sex
Number of subjects: 3357
Study: 7485711

Group type: EXPERIMENTAL
Intervention: Oral artesunate (4 mg/kg/day for three days with mefloquine 25 mg/kg on the second day)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Intravenous quinine (20 mg of salt/kg initially then 10 mg/kg every 8 hr, followed by mefloquine 25 mg/kg)
Number of subjects: 60
Study: 1775483

Group type: EXPERIMENTAL
Intervention: AmF/SnF2 toothpaste and AmF/SnF2 mouthwash
Number of subjects: 44

Group type: COMPARATOR
Intervention: NaF toothpaste and NaF mouthwash
Number of subjects: 44
Study: 6821197

Group type: EXPERIMENTAL
Intervention: 2% sodium cromoglycate eye drops
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 4% sodium cromoglycate eye drops
Number of subjects: 0
Study: 31028737

Group type: EXPERIMENTAL
Intervention: Buccal infiltration of 4% articaine 1.8 mL
Number of subjects: 72

Group type: COMPARATOR
Intervention: Buccal infiltration of 4% articaine 1.8 mL plus lingual injection of normal saline 0.4 mL
Number of subjects: 72
Study: 28408335

Group type: EXPERIMENTAL
Intervention: PCST-Full (5 sessions)
Number of subjects: 327

Group type: EXPERIMENTAL
Intervention: PCST-Brief (1 session of 60 minutes)
Number of subjects: 327

Group type: COMPARATOR
Intervention: Additional PCST sessions, maintenance calls, or no further intervention (based on intervention response)
Number of subjects: 327
Study: 27164977

Group type: EXPERIMENTAL
Intervention: Hyperextension maneuver during autograft fixation on the tibial side
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no hyperextension maneuver)
Number of subjects: 100
Study: 24099546

Group type: EXPERIMENTAL
Intervention: Counting-on from current number on the board while playing a 0-100 number board game
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard count-from-1 procedure while playing the same game
Number of subjects: 0

Group type: COMPARATOR
Intervention: Practice encoding the numerals 1-100 outside of the context of a number board game
Number of subjects: 0
Study: 22018594

Group type: EXPERIMENTAL
Intervention: 30 mg somatuline® (lanreotide) administered by a single subcutaneous injection for 2 weeks (Group B)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Paclitaxel 190 mg/m2 + carboplatin AUC=5.5 for up to 6 cycles (Group A, control group)
Number of subjects: 130

Group type: COMPARATOR
Intervention: 60 mg somatuline® autogel for 4 weeks (Group C)
Number of subjects: 130
Study: 19073237

Group type: EXPERIMENTAL
Intervention: Depressive participants
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-depressive participants
Number of subjects: 0
Study: 17428109

Group type: EXPERIMENTAL
Intervention: Exenatide (subcutaneous, twice daily)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Exenatide
Number of subjects: 0
Study: 15522938

Group type: EXPERIMENTAL
Intervention: Cinacalcet (30-50 mg twice daily)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Cinacalcet
Number of subjects: 78

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study: 12228208

Group type: EXPERIMENTAL
Intervention: Fludarabine plus chlorambucil
Number of subjects: 544

Group type: EXPERIMENTAL
Intervention: Fludarabine
Number of subjects: 544

Group type: COMPARATOR
Intervention: Chlorambucil
Number of subjects: 544
Study: 10093649

Group type: EXPERIMENTAL
Intervention: GHB
Number of subjects: 42

Group type: COMPARATOR
Intervention: Flunitrazepam (Control)
Number of subjects: 42
Study: 7486180

Group type: EXPERIMENTAL
Intervention: ondansetron (0.1 mg/kg)
Number of subjects: 102

Group type: COMPARATOR
Intervention: placebo (normal saline)
Number of subjects: 102

Group type: COMPARATOR
Intervention: droperidol (75 micrograms/kg)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: ondansetron
Number of subjects: 102
Study: 2403058

Group type: EXPERIMENTAL
Intervention: Exercise (Ex) group walking at 60% heart‐rate reserve (134 +/- 2 bpm) for 45-min sessions, five times per week
Number of subjects: 21

Group type: COMPARATOR
Intervention: Nonexercise (Nex) group
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Both Ex and Nex groups
Number of subjects: 21
Study: 7358847

Group type: EXPERIMENTAL
Intervention: Medroxyprogesterone acetate (4 weeks)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 31106492

Group type: EXPERIMENTAL
Intervention: Transitioning to very low nicotine content cigarettes plus nicotine patch
Number of subjects: 68

Group type: COMPARATOR
Intervention: Reducing daily cigarette consumption plus nicotine patch
Number of subjects: 68
Study: 28402516

Group type: EXPERIMENTAL
Intervention: Minimally invasive surgery plus recombinant Tissue plasminogen activator (rtPA)
Number of subjects: 123
Study: 26289560

Group type: EXPERIMENTAL
Intervention: Delphi feedback methods (three different methods)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Core outcome set
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Consensus meeting
Number of subjects: 0
Study: 23011257

Group type: EXPERIMENTAL
Intervention: TVT (Gynecare(®))
Number of subjects: 71

Group type: COMPARATOR
Intervention: TOT (Aris(®))
Number of subjects: 71
Study: 21419770

Group type: EXPERIMENTAL
Intervention: peginterferon alfa‐2b (0.5 μg/kg/week)
Number of subjects: 626

Group type: COMPARATOR
Intervention: No treatment (controls)
Number of subjects: 626
Study: 19046169

Group type: EXPERIMENTAL
Intervention: Lactobacillus-containing vaginal tablets
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 17429915

Group type: EXPERIMENTAL
Intervention: rhEPO (250 IU/kg three times weekly, total of 15 times starting on day of life 5)
Number of subjects: 31
Study: 12671188

Group type: EXPERIMENTAL
Intervention: Aerobic training
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Resistance training
Number of subjects: 26
Study: 10867388

Group type: EXPERIMENTAL
Intervention: Therapeutic strategy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Clinical tests
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Integral valuation of treatment
Number of subjects: 0
Study: 8772901

Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation to both mother and infant (300,000 IU for mothers and 200,000 IU for infants)
Number of subjects: 909

Group type: COMPARATOR
Intervention: Vitamin A supplementation to mother and placebo to infant
Number of subjects: 909

Group type: COMPARATOR
Intervention: Placebo to both mother and infant
Number of subjects: 909
Study: 1308804

Group type: EXPERIMENTAL
Intervention: Total intravenous anesthesia with propofol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Inhalational anesthesia with halothane
Number of subjects: 0
Study: 6442856

Group type: EXPERIMENTAL
Intervention: Semi-elemental diet (SED) with an osmolarity of 302 milliosmol per liter, low lactose content, and high lactalbumin hydrolysate (1 g/100 ml)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Available proprietary formulas or diluted cow's milk with added carbohydrates
Number of subjects: 38
Study: 3717617

Group type: EXPERIMENTAL
Intervention: Rüsch tube with low residual volume cuff, inflated to minimum occluding volume
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Mallinckrodt Hi‐Lo tube with high residual volume cuff, inflated to 29‐31 cm H2O
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: NL tube with high residual volume cuff and automatic cuff pressure regulation, inflated to 29‐31 cm H2O
Number of subjects: 47
Study: 29564932

Group type: EXPERIMENTAL
Intervention: U‐200 lispro
Number of subjects: 126

Group type: COMPARATOR
Intervention: U‐100 lispro
Number of subjects: 126
Study: 26604159

Group type: EXPERIMENTAL
Intervention: Magnesium sulfate (MgSO4) for 12 hours (loading dose 4g IV, maintenance 1g/hour)
Number of subjects: 204

Group type: COMPARATOR
Intervention: Magnesium sulfate (MgSO4) for 24 hours (loading dose 4g IV, maintenance 1g/hour)
Number of subjects: 204
Study: 25740794

Group type: EXPERIMENTAL
Intervention: valACV 500 mg twice daily for 12 weeks
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 24371878

Group type: COMPARATOR
Intervention: Silver alloy-coated catheters
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nitrofurazone-impregnated catheters
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Standard catheters
Number of subjects: 0
Study: 20156979

Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training (IMT)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Breathing retraining (BRT)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 45
Study: 18619359

Group type: EXPERIMENTAL
Intervention: Bailing capsule and medical gymnastics
Number of subjects: 50

Group type: COMPARATOR
Intervention: Routine western medicine (Control)
Number of subjects: 50
Study: 17235419

Group type: EXPERIMENTAL
Intervention: Direct stenting
Number of subjects: 95

Group type: COMPARATOR
Intervention: Balloon predilatation followed by stenting
Number of subjects: 95
Study: 12568831

Group type: EXPERIMENTAL
Intervention: 2 mg of E2
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: 2 mg of E2 + 5 mg of medroxyprogesterone acetate (MPA)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study: 11082818

Group type: EXPERIMENTAL
Intervention: Oxcarbazepine (OXC)
Number of subjects: 200000
Study: 8854286

Group type: EXPERIMENTAL
Intervention: Theophylline Lavipharm (200 mg or 300 mg)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Theodur (200 mg or 300 mg)
Number of subjects: 48
Study: 1607899

Group type: EXPERIMENTAL
Intervention: Outdoor air ventilation at 10 cfmpp
Number of subjects: 254

Group type: EXPERIMENTAL
Intervention: Outdoor air ventilation at 20 cfmpp
Number of subjects: 254

Group type: EXPERIMENTAL
Intervention: Outdoor air ventilation at 50 cfmpp
Number of subjects: 254

Group type: EXPERIMENTAL
Intervention: Blinding to the intervention
Number of subjects: 254

Group type: EXPERIMENTAL
Intervention: Weekly non-response
Number of subjects: 254
Study: 6092012

Group type: EXPERIMENTAL
Intervention: cefotaxime 3 x 2 g
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: lamoxactam 3 x 2 g
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: cefmenoxime 3 x 1 g
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: mezlocillin 3 x 5 g
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: piperacillin 3 x 4 g
Number of subjects: 100
Study: 31121926

Group type: EXPERIMENTAL
Intervention: Oral Nutritional Supplements (ONS) - 2 packs daily for 8 weeks
Number of subjects: 34

Group type: COMPARATOR
Intervention: Non-Oral Nutritional Supplements (non-ONS)
Number of subjects: 34
Study: 28934067

Group type: EXPERIMENTAL
Intervention: Gaze stability exercises for 10 minutes
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (resting)
Number of subjects: 0
Study: 26798037

Group type: EXPERIMENTAL
Intervention: Sensei X™ robotic navigation system (RNS) during pulmonary vein isolation (PVI) procedures
Number of subjects: 80
Study: 25200644

Group type: EXPERIMENTAL
Intervention: Spinal anesthesia
Number of subjects: 68

Group type: COMPARATOR
Intervention: General anesthesia
Number of subjects: 68
Study: 21807474

Group type: EXPERIMENTAL
Intervention: Information film presented as a complement to written and verbal information
Number of subjects: 390

Group type: COMPARATOR
Intervention: Control group (no information film)
Number of subjects: 390

Group type: EXPERIMENTAL
Intervention: Information film
Number of subjects: 390
Study: 20137063

Group type: EXPERIMENTAL
Intervention: Naprapathic manual therapy (spinal manipulation/mobilization, massage, and stretching)
Number of subjects: 409

Group type: COMPARATOR
Intervention: Advice to stay active and cope with pain (Control Group)
Number of subjects: 409
Study: 18045283

Group type: EXPERIMENTAL
Intervention: Zinc sulfate
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study: 15640478

Group type: EXPERIMENTAL
Intervention: Calcium supplementation (approximately 670 mg/d)
Number of subjects: 354

Group type: EXPERIMENTAL
Intervention: Calcium supplementation
Number of subjects: 354
Study: 12360174

Group type: EXPERIMENTAL
Intervention: Intravenous monteplase pretreatment before coronary angioplasty (Group II)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Direct coronary angioplasty (Group I)
Number of subjects: 154
Study: 10807887

Group type: EXPERIMENTAL
Intervention: Orlistat 120 mg three times daily
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 9010610

Group type: EXPERIMENTAL
Intervention: sustained-release ibuprofen (1600 mg daily)
Number of subjects: 61

Group type: COMPARATOR
Intervention: sustained-release diclofenac sodium (100 mg daily)
Number of subjects: 61
Study: 1621533

Group type: EXPERIMENTAL
Intervention: Post-halftime warm-up and stretching routine (3 minutes)
Number of subjects: 108

Group type: COMPARATOR
Intervention: No warm-up and stretching intervention (Control)
Number of subjects: 108
Study: 3883375

Group type: EXPERIMENTAL
Intervention: Epinephrine solution instillation into the breast parenchyma
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control solution
Number of subjects: 0
Study: 30100576

Group type: EXPERIMENTAL
Intervention: Epworth Sleepiness Scale (ESS) intervention
Number of subjects: 639

Group type: EXPERIMENTAL
Intervention: Proposed MID for the ESS
Number of subjects: 639
Study: 28967710

Group type: EXPERIMENTAL
Intervention: Individualized counselling intervention
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 30
Study: 27173169

Group type: EXPERIMENTAL
Intervention: Smartphone-based self-management system
Number of subjects: 47
Study: 24043484

Group type: EXPERIMENTAL
Intervention: S-cTnI assay
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: hs-cTnT assay
Number of subjects: 222
Study: 22623888

Group type: EXPERIMENTAL
Intervention: Dejian mind-body intervention (DMBI)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 75
Study: 20735834

Group type: EXPERIMENTAL
Intervention: Thymostimulin 75 mg s.c. 5x/week
Number of subjects: 135

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 135
Study: 18242365

Group type: EXPERIMENTAL
Intervention: Pentosan polysulfate sodium (PPS) 300 mg/day for 32 weeks
Number of subjects: 128
Study: 15986237

Group type: EXPERIMENTAL
Intervention: Exercise training for 3 months
Number of subjects: 139
Study: 12704967

Group type: EXPERIMENTAL
Intervention: Web‐based instructional format
Number of subjects: 33

Group type: COMPARATOR
Intervention: Slide/audiotape instructional format
Number of subjects: 33
Study: 10411795

Group type: EXPERIMENTAL
Intervention: Clomiphene (50 mg days 5 to 9)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Control cycles
Number of subjects: 5
Study: 7756105

Group type: EXPERIMENTAL
Intervention: Amantadine HCl (3 mg kg‐1)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Chronic tobacco smoking
Number of subjects: 20
Study: 2310250

Group type: EXPERIMENTAL
Intervention: Cefamandole nafate
Number of subjects: 400

Group type: COMPARATOR
Intervention: Cefonicid
Number of subjects: 400
Study: 7014656

Group type: EXPERIMENTAL
Intervention: Propiram fumarate (50 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pentazocine (50 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Codeine (60 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31204198

Group type: EXPERIMENTAL
Intervention: Single shot of intravenous TXA 10 mg/kg
Number of subjects: 176

Group type: COMPARATOR
Intervention: Normal saline (Control group)
Number of subjects: 176
Study: 27989852

Group type: EXPERIMENTAL
Intervention: 30mg morphine
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 26487746

Group type: EXPERIMENTAL
Intervention: Curved edge catheter (Tiemann type)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional suction catheter
Number of subjects: 20
Study: 23085096

Group type: EXPERIMENTAL
Intervention: Endoscopic sphincterotomy with balloon dilation (ESBD)
Number of subjects: 156

Group type: COMPARATOR
Intervention: Endoscopic sphincterotomy (ES)
Number of subjects: 156
Study: 20479767

Group type: EXPERIMENTAL
Intervention: Body-weight-supported treadmill (BWST) training
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Tilt-table standing (TTS) training
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Single session of BWST
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Single session of TTS
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: BWST and TTS training
Number of subjects: 7
Study: 18723314

Group type: EXPERIMENTAL
Intervention: Gemcitabine + Tipifarnib (G+t)
Number of subjects: 244

Group type: COMPARATOR
Intervention: Gemcitabine + Placebo (G+p)
Number of subjects: 244
Study: 16702498

Group type: COMPARATOR
Intervention: Tazarotene gel plus placebo capsules
Number of subjects: 189

Group type: COMPARATOR
Intervention: Minocycline capsules plus vehicle gel
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Tazarotene gel plus minocycline capsules
Number of subjects: 189
Study: 15611422

Group type: EXPERIMENTAL
Intervention: Oral alitretinoin 10 mg/d
Number of subjects: 319

Group type: EXPERIMENTAL
Intervention: Oral alitretinoin 20 mg/d
Number of subjects: 319

Group type: EXPERIMENTAL
Intervention: Oral alitretinoin 40 mg/d
Number of subjects: 319

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 319
Study: 11697833

Group type: EXPERIMENTAL
Intervention: Early hyperfractionated thoracic radiation therapy (HTRT) concurrently with the first cycle of chemotherapy (Group A)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Late hyperfractionated thoracic radiation therapy (HTRT) concurrently with the fourth cycle of chemotherapy (Group B)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Comparison of early vs late HTRT
Number of subjects: 81
Study: 9397246

Group type: EXPERIMENTAL
Intervention: Amlodipine (5 or 10 mg)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Diltiazem (180, 240, or 360 mg)
Number of subjects: 123
Study: 7978566

Group type: EXPERIMENTAL
Intervention: Intravenous prochlorperazine (10 mg)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Rectal prochlorperazine (25 mg)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Intravenous prochlorperazine
Number of subjects: 45

Group type: COMPARATOR
Intervention: Rectal prochlorperazine
Number of subjects: 45
Study: 2498820

Group type: EXPERIMENTAL
Intervention: Autoinflation (3 times daily for 2 weeks)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Observation (control group)
Number of subjects: 41
Study: 1041750

Group type: EXPERIMENTAL
Intervention: Penicillin G
Number of subjects: 84

Group type: COMPARATOR
Intervention: Clindamycin
Number of subjects: 84
Study: 31434782

Group type: EXPERIMENTAL
Intervention: SBRT monotherapy (40 Gy in five fractions given on alternating days)
Number of subjects: 472

Group type: EXPERIMENTAL
Intervention: Virtual high-dose rate boost (HDRB) (20 Gy in two fractions followed by 36 Gy in 12 fractions)
Number of subjects: 472
Study: 28158982

Group type: EXPERIMENTAL
Intervention: Levothyroxine treatment (50 micrograms daily, titrated according to TSH level)
Number of subjects: 750

Group type: COMPARATOR
Intervention: Placebo (mock titration)
Number of subjects: 750

Group type: EXPERIMENTAL
Intervention: Levothyroxine treatment
Number of subjects: 750
Study: 25959908

Group type: EXPERIMENTAL
Intervention: Milk containing 600 IU Vitamin D/1000cc
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Milk containing 1000 IU Vitamin D/1000cc
Number of subjects: 0

Group type: COMPARATOR
Intervention: Whole milk (non-fortified)
Number of subjects: 0
Study: 22828004

Group type: EXPERIMENTAL
Intervention: Genome-wide association studies (GWAS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Harmonized case control definitions
Number of subjects: 0